Zurich Cantonal Bank’s AC Immune ACIU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-3,123
Closed -$8.43K 2626
2024
Q4
$8.43K Sell
3,123
-540
-15% -$1.69K ﹤0.01% 2612
2024
Q3
$13.8K Sell
3,663
-188
-5% -$656 ﹤0.01% 2607
2024
Q2
$15.4K Sell
3,851
-68
-2% -$225 ﹤0.01% 2600
2024
Q1
$11.6K Buy
+3,919
New +$14K ﹤0.01% 2648

Other funds holding ACIU

Zurich Cantonal Bank's ACIU Position: Q1 2025 in Review

Zurich Cantonal Bank sold out of AC Immune (ACIU) in Q1 2025, closing a stake of 3,123 shares — an estimated $8.43K sold.

Zurich Cantonal Bank first reported a position in ACIU in Q1 2024 and held it in 4 quarters. The position peaked at $15.4K in Q2 2024. 41 funds tracked by Wall St. Rank hold ACIU as of Q1 2025.

  • Zurich Cantonal Bank reported no remaining AC Immune position as of Q1 2025 after selling out during the quarter.
  • Zurich Cantonal Bank sold 3,123 AC Immune shares in Q1 2025, an estimated $8.43K.
  • Zurich Cantonal Bank first reported a position in AC Immune in Q1 2024 and held it in 4 quarters.
  • Zurich Cantonal Bank's AC Immune position peaked at $15.4K in Q2 2024.
  • 41 funds tracked by Wall St. Rank held AC Immune as of Q1 2025.

Based on Zurich Cantonal Bank's 13F filing for Q1 2025, filed 7 May 2025.